The Vanderbilt-lngram Cancer Center (VICC) employs both internal and external review mechanisms to inform and support the strategic decisions made by the center and to provide feedback necessary for ongoing evaluation of the effectiveness of those decisions. Program Planning and Evaluation provides a structured approach for assessing our current status relative to strategic planning, identifying opportunities and formulating approaches for implementing the mission of the VICC. These processes ensure effective and well-coordinated use of Cancer Center Support Grant (CCSG) resources, institutional discretionary support and philanthropic funds. The significant progress of the VICC, described throughout this renewal application, continues to provide evidence in support of the effective use of both internal and external planning and evaluation processes. The Director has the ultimate responsibility and authority for setting priorities for the development of new research programs and shared resources;recruiting and retaining scientists and scientific leaders;selecting programs, projects and individuals to receive seed grant funding; determining use of VICC space and resources;and organizing the Center as a whole to promote scientific interactions and enhance productivity. To ensure the Director receives the best advice possible, she relies on several committees for identifying short- and long-term initiatives, implementing policies, evaluating processes and participating in decision-making activities. These working groups help manage Center affairs as well as provide the setting for the Senior Leaders to exchange ideas with Program Leaders, Shared Resource Managers, and External Advisors. Internal groups include the Executive Committee, Research Program Leaders Committee, Shared Resource Oversight Group, Minority Affairs and Health Disparities Taskforce, Translational and Therapeutic Taskforce Committee, Cancer Clinical Enterprise Committee and the Clinical Enterprise Executive Committee. Two external groups provide opportunities for comprehensive planning and evaluation processes within the VICC, the External Scientific Advisory Board and the Board of Overseers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733533
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$118,578
Indirect Cost
$89,304
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Yang, Yaohua; Cai, Qiuyin; Shu, Xiao-Ou et al. (2018) Prospective study of oral microbiome and colorectal cancer risk in low-income and African American populations. Int J Cancer :

Showing the most recent 10 out of 2462 publications